PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES Tender

• Country: USA
• Summary: PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES pSMILE
• UST Ref No: 133408233
• Deadline: 23 Jan 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 75N93025R00011
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Background
  The Division of AIDS (DAIDS) in the National Institute of Allergy and Infectious Diseases (NIAID) supports a global research portfolio to advance biological knowledge of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), its related co-infections, and its co-morbidities. With the ultimate goal of creating an “AIDS-Free Generation,” DAIDS develops and supports the infrastructure and biomedical research needed to: 1) reduce HIV incidence through the development of an effective vaccine and biomedical prevention strategies that are safe and desirable; 2) develop novel approaches for the treatment and cure of HIV infection; 3) develop interventions to treat and/or prevent HIV co-infections and co-morbidities of greatest significance; and 4) foster partnerships with scientific and community stakeholders to develop and implement effective interventions. NIAID supports four HIV/AIDS clinical trial networks as part of its HIV clinical research enterprise. High quality test results support the safety of study participants and the reliability of study results. DAIDS employs a variety of Laboratory Quality Assurance oversight contractual resources to monitor and enhance the ability of laboratories to accurately and reliably perform trial-specified clinical laboratory testing (https://www.niaid.nih.gov/research/daids-clinical-research-policies-standard-procedures).
  SMILE will continue to serve current and future NIAID-sponsored clinical trial networks and collaborating study groups (User Groups), as well as individual grantees conducting clinical research. The current contract supports approximately 150 laboratories in 18 countries.
  The current contract has been held by Johns Hopkins University, Baltimore, Maryland since its inception in 2004. The current contract is held under contract number 75N93020C00001. The period of performance of the current contract is November 15, 2019 through November 14, 2026.
  Purpose and Objectivesb...
• Documents:

 Tender Notice